ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1046

The Level of RF or Anti-CCP Antibody Affect Ultrasound Synovial Findings in Patients with Rheumatoid Arthritis?

Tadashi Okano1, Kenji Mamoto1, Yutaro Yamada1, Shohei Anno2, Yuka Domae1, Shingo Washida1, Asami Yagami1, Yuko Yoshida1, Tatsuya Koike3 and Hiroaki Nakamura1, 1Osaka Metropolitan University, Osaka, Japan, 2Yodogawa Christian Hospital, Osaka, Japan, 3Search Institute for Bone and Arthritis Disease (SINBAD), Shirahama Foundation for Health and Welfare, Shirahama, Japan

Meeting: ACR Convergence 2023

Keywords: Anti-CCP, Rheumatoid Factor, Synovitis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1033–1051) Imaging of Rheumatic Diseases Poster I

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Positive for auto-antibodies such as rheumatoid factor (RF) and anti-citrullinated peptide antibodies (CCP) or having high autoantibody titers is associated with the progression of joint destruction in patients with rheumatoid arthritis (RA) (van Steenbergen HW, et al. Ann Rheum Dis. 2015;74:e3. and Hecht C, et al. Ann Rheum Dis. 2015;74:2151-6.). Therefore, we evaluated the relationship between RF or CCP levels and ultrasound synovial findings.

Methods: A total of 750 RA patients who underwent ultrasound examination from January 2017 to August 2020 were continuously included. Ultrasound examination was performed at the of bilateral first to fifth metacarpophalangeal (MCP) joints, first interphalangeal (IP) and second to fifth proximal interphalangeal (PIP) joints, wrist joints (three part of radial, medial and ulnar) and first to fifth metatarsophalangeal (MTP) joints. Both grayscale (GS) and power Doppler (PD) findings were scored to grade 0-3 by a semi-quantitative method, and the sum of GS was defined as the GS score and the sum of PD as the PD score. Patients were classified into a negative group and a positive group according to RF and CCP titers, and the positive group was further classified into quartiles (Q1-Q4) according to those levels, and disease activity and ultrasound synovial findings were compared.

Results: There were 655 cases in the RF positive group and 565 cases in the CCP positive group. RF positive group were divided into quartiles such as Q1: 15 < RF ≤ 72, Q2: 72 < RF ≤ 158, Q3: 72 < RF ≤ 379, Q4: 379 < RF ≤ 8160, and CCP positive group were divided into quartiles such as Q1: 4.5 ≤ CCP ≤ 36.0, Q2: 36.0 < CCP ≤ 95.6, Q3: 95.6 < CCP ≤ 308.0, Q4: 308.0 < CCP. There was no difference in disease duration or disease activity both in the RF and CCP positive group and the negative group, but the ultrasound synovitis scores were significantly worse in both GS and PD score in the positive groups. Among the RF and CCP positive groups, the ultrasound synovitis score tended to be high in the high RF and CCP group, and the highest in the Q4 group.

Conclusion: We evaluated the relationship between RF or CCP levels and ultrasound synovitis. Ultrasound synovial findings were significantly worse in positive group than negative group on both RF and CCP, regardless of disease activity. Moreover, high titer of RF or CCP levels tended to be higher ultrasound synovitis. Patients with high titer of RF or CCP levels should be considered to treat more earlier and intensively.

Supporting image 1

Figure 1. The relattionship between RF titer and disease activity or ultrasound findings.

Supporting image 2

Figure 1. The relattionship between anti-CCP antibody titer and disease activity or ultrasound findings.


Disclosures: T. Okano: None; K. Mamoto: None; Y. Yamada: None; S. Anno: None; Y. Domae: None; S. Washida: None; A. Yagami: None; Y. Yoshida: None; T. Koike: None; H. Nakamura: None.

To cite this abstract in AMA style:

Okano T, Mamoto K, Yamada Y, Anno S, Domae Y, Washida S, Yagami A, Yoshida Y, Koike T, Nakamura H. The Level of RF or Anti-CCP Antibody Affect Ultrasound Synovial Findings in Patients with Rheumatoid Arthritis? [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/the-level-of-rf-or-anti-ccp-antibody-affect-ultrasound-synovial-findings-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-level-of-rf-or-anti-ccp-antibody-affect-ultrasound-synovial-findings-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology